Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,073 | 63 | 91.5% |
| Education | $99.99 | 1 | 8.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $212.43 | 12 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $201.41 | 9 | $0 (2024) |
| Lilly USA, LLC | $139.85 | 9 | $0 (2023) |
| Novo Nordisk Inc | $114.06 | 7 | $0 (2024) |
| Axsome Therapeutics, Inc. | $95.58 | 6 | $0 (2023) |
| Astellas Pharma US Inc | $71.13 | 4 | $0 (2024) |
| Inspire Medical Systems, Inc. | $54.51 | 1 | $0 (2023) |
| Abbott Laboratories | $52.76 | 3 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $40.19 | 3 | $0 (2023) |
| DEXCOM, INC. | $36.13 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $261.46 | 15 | ABBVIE INC. ($100.34) |
| 2023 | $496.11 | 23 | Harmony Biosciences LLC ($157.82) |
| 2022 | $237.97 | 14 | Lilly USA, LLC ($42.96) |
| 2021 | $177.50 | 12 | AbbVie Inc. ($58.20) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Biological | ||||||
| 08/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Endocrinology | ||||||
| 08/24/2024 | ABBVIE INC. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Respiratory | ||||||
| 07/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: Biological | ||||||
| 07/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Biological | ||||||
| 07/08/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Endocrinology | ||||||
| 06/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Biological | ||||||
| 05/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Diabetes | ||||||
| 02/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: NEUROSCIENCE | ||||||
| 01/16/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $13.96 | General |
| Category: Narcoplepsy | ||||||
| 12/21/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Diabetes Care | ||||||
| 12/19/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: INSOMNIA | ||||||
| 12/08/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $54.51 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Diabetes | ||||||
| 12/01/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Education | Cash or cash equivalent | $99.99 | General |
| Category: SLEEP MEDICINE | ||||||
| 11/30/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Neurology | ||||||
| 11/29/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $12.36 | General |
| Category: SLEEP MEDICINE | ||||||
| 09/27/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes | ||||||
| 09/18/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: INSOMNIA | ||||||
| 09/16/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $17.68 | General |
| Category: SLEEP MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 182 | 250 | $40,217 | $15,462 |
| 2022 | 4 | 172 | 281 | $36,930 | $14,759 |
| 2021 | 3 | 155 | 265 | $41,163 | $18,304 |
| 2020 | 12 | 657 | 1,066 | $126,487 | $50,134 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 103 | $18,118 | $7,285 | 40.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 73 | $8,456 | $3,248 | 38.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 18 | 18 | $7,086 | $2,459 | 34.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 16 | 16 | $4,296 | $1,706 | 39.7% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 25 | 25 | $1,420 | $537.25 | 37.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 15 | 15 | $841.00 | $226.20 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 141 | $23,410 | $9,074 | 38.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 111 | $12,261 | $5,054 | 41.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 14 | 14 | $854.00 | $336.00 | 39.3% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 15 | 15 | $405.00 | $295.26 | 72.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 77 | 145 | $23,470 | $10,859 | 46.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 60 | 102 | $10,944 | $4,958 | 45.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 18 | 18 | $6,749 | $2,486 | 36.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 233 | 458 | $72,828 | $27,992 | 38.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 158 | 303 | $32,118 | $11,887 | 37.0% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 14 | 14 | $3,948 | $3,182 | 80.6% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 71 | 71 | $1,750 | $1,370 | 78.3% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 11 | 11 | $1,617 | $1,303 | 80.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 67 | 68 | $3,876 | $1,103 | 28.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 11 | 11 | $2,739 | $1,052 | 38.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 11 | 11 | $2,850 | $874.11 | 30.7% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 13 | 22 | $3,049 | $769.14 | 25.2% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 17 | 24 | $768.00 | $231.71 | 30.2% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2020 | 12 | 24 | $552.00 | $201.03 | 36.4% |
| 81002 | Urinalysis, manual test | Office | 2020 | 39 | 49 | $392.00 | $169.33 | 43.2% |
About Casey Carter
Casey Carter is a Physician Assistant healthcare provider based in Roosevelt, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/10/2015. The National Provider Identifier (NPI) number assigned to this provider is 1225406077.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Casey Carter has received a total of $1,173 in payments from pharmaceutical and medical device companies, with $261.46 received in 2024. These payments were reported across 64 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,073).
As a Medicare-enrolled provider, Carter has provided services to 1,166 Medicare beneficiaries, totaling 1,862 services with total Medicare billing of $98,659. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Roosevelt, UT
- Active Since 09/10/2015
- Last Updated 09/10/2015
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1225406077
Products in Payments
- VRAYLAR (Drug) $204.43
- WAKIX (Drug) $171.78
- Sunosi (Drug) $95.58
- Ozempic (Drug) $89.06
- Veozah (Drug) $71.13
- TRULICITY (Drug) $70.24
- INSPIRE (Device) $54.51
- QUVIVIQ (Drug) $40.19
- FREESTYLE LIBRE 2 (Device) $39.95
- EMGALITY (Drug) $37.52
- DEXCOM G6 TRANSMITTER (Device) $36.13
- MOUNJARO (Drug) $32.09
- Korlym (Drug) $31.28
- Wakix (Drug) $29.63
- WatchPATONE (Device) $27.99
- NURTEC ODT (Drug) $27.48
- XYWAV (Drug) $26.83
- Rybelsus (Drug) $25.00
- VIBERZI (Drug) $21.96
- AIRSUPRA (Drug) $15.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Roosevelt
Albert Stone, Pa-C, PA-C
Physician Assistant — Payments: $1,409
Reanell Gasaway, Pa, PA
Physician Assistant — Payments: $701.32
Noel Christian Guido, Pa-C, PA-C
Physician Assistant — Payments: $481.71
Dr. Darwin Mckee, P.a.-C, P.A.-C
Physician Assistant — Payments: $154.67
Clark Sessions, Pa-C, PA-C
Physician Assistant — Payments: $90.72
Bryce Pace
Physician Assistant — Payments: $76.78